Earnings per share of CSL Ltd Australia FY 2015-2019

Published by Statista Research Department, Apr 3, 2024
The 2019 financial year saw the average earnings per share of Melbourne-based CSL Limited increase to 4.24 U.S. dollars. CSL Limited is a global biotechnology company that is involved in the research, development, manufacturing, and marketing of products used to treat human medical conditions.

Earnings per share of CSL Limited in Australia from financial year 2015 to 2019 (in U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

September 2019

Region

Australia

Survey time period

financial year 2015 to 2019

Supplementary notes

Australia's financial year runs from July 1 to June 30; for example, financial year 2017 starts on July 1, 2016 and ends on June 30, 2017.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Immunization rates in the United Kingdom (UK) "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Immunization rates in the United Kingdom (UK)

Mumps, Measles and Rubella vaccine

6

Pneumococcal Vaccine (PCV)

5

DTP/Pol/Hib vaccine

6

HPV immunization

5

Prevalence of preventable diseases

4

Attitudes towards vaccinations

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

COVID-19 pandemic labor lawsuits in the U.S.Workplace health and wellness in the U.S.Vaccine hesitancy in the U.S.Coronavirus (COVID-19) in the U.S.Coronavirus (COVID-19): impact on the retail landscape in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.